Skip to content

Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjdementia
VJNeurology
Logo
  • Home (current)
  • Diseases
    Parkinson's Disease
    Multiple Sclerosis and Related Disorders
    Headache
    Amyotrophic Lateral Sclerosis
    Epilepsy
    Sleep Disorders
    Stroke
    Neuromuscular Disorders
    Movement Disorders
    View all Diseases
  • Topics
    Biology
    Diagnostics
    Trial Updates
    Treatment
    Prevention
    Surgery
    Imaging
    Genetics
    COVID-19
    View all Topics
  • Conferences
    AAN 2023
    BNA 2023
    AD/PD 2023
    CONy 2023
    ACTRIMS 2023
    ISC 2023
    View all Conferences
  • Features
  • Podcasts
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Interferon-beta

Self-reported adherence and safety from the MASTER-2 & CLICK-MS studies of cladribine in MS patients 3:21
Self-reported adherence and safety from the MASTER-2 & CLICK-MS studies of cladribine in MS patients
Emily Evans • 21 Feb 2023
Current recommendations on MS treatment during pregnancy 1:46
Current recommendations on MS treatment during pregnancy
Eva Kubala Havrdová • 27 Oct 2022
Managing MS relapses during pregnancy 2:25
Managing MS relapses during pregnancy
Kristen Krysko • 4 Apr 2022
COVID booster vaccines do not lead to humoral responses in patients with MS treated with DMTs 1:57
COVID booster vaccines do not lead to humoral responses in patients with MS treated with DMTs
Celia Oreja-Guevara • 24 Feb 2022
How to approach MS treatment sequencing in a crowded therapeutic market 1:13
How to approach MS treatment sequencing in a crowded therapeutic market
Jeffrey Cohen • 24 Feb 2022
A score to predict treatment response in pediatric patients with multiple sclerosis 3:26
A score to predict treatment response in pediatric patients with multiple sclerosis
Ermelinda De Meo • 27 Oct 2021
Humoral response to COVID-19 vaccination in patients with MS 6:28
Humoral response to COVID-19 vaccination in patients with MS
Celia Oreja-Guevara • 14 Oct 2021
Challenges with COVID-19 & MS registries 3:04
Challenges with COVID-19 & MS registries
Maria Pia Sormani • 13 Oct 2021
Update on pediatric NMOSD and MOGAD 3:47
Update on pediatric NMOSD and MOGAD
Brenda Banwell • 26 Apr 2021
DMTs and risk for severe COVID-19 in multiple sclerosis patients 2:51
DMTs and risk for severe COVID-19 in multiple sclerosis patients
Maria Pia Sormani • 6 Apr 2021
Immunomodulatory effects of vitamin D in MS 3:13
Immunomodulatory effects of vitamin D in MS
Jorge Correale • 5 Mar 2021
The problem with defining types of MS 3:10
The problem with defining types of MS
Gavin Giovannoni • 19 Oct 2020
Therapeutic options in multiple sclerosis 4:08
Therapeutic options in multiple sclerosis
Celia Oreja-Guevara • 24 May 2020
Journal Pages
  • Diseases
  • Topics
  • Medicines
  • Trials
  • Conferences
  • Features
Newsletter

Receive the latest news and videos from VJNeurology via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJNeurology logo
The content of VJNeurology is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy